New combo therapy shows promise for three tough cancers
Disease control
Completed
This study tested a new combination of two drugs (IO102-IO103 and pembrolizumab) as a first treatment for people with advanced lung, head/neck, or bladder cancer that has spread. A total of 63 patients took part. The goal was to see if the combo is safe and shrinks tumors. This i…
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated Jun 17, 2026 20:19 UTC